Trials / Completed
CompletedNCT04855188
Effectiveness and Safety of YVOIRE Y-Solution 540
A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 394 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 versus YVOIRE volume plus in Nasolabial Folds Injection
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | YVOIRE Y-Solution 540 | Injection into the deep dermis layer and/or subcutaneous layer in the nasolabial folds based on the randomization assignment. |
| DEVICE | YVOIRE volume plus | Injection into the deep dermis layer and/or subcutaneous layer in the nasolabial folds based on the randomization assignment. |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2022-09-29
- Completion
- 2024-07-14
- First posted
- 2021-04-22
- Last updated
- 2024-12-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04855188. Inclusion in this directory is not an endorsement.